Synova Invests Growth Capital in Unity Five Limited

Synova Invests in Mallcomm

November 1, 2022

Cloud & SaaS

Growth investor Synova has made an investment in Mallcomm to support a management buyout led by CEO David Fuller‑Watts. The capital will accelerate product development, support strategic M&A and geographic expansion of Mallcomm's PropTech SaaS platform, and brings Chris Blaxall onto the board as Executive Chairman.

Quad-C Management Acquires Majority Stake in Synoptek from Sverica Capital

September 27, 2022

IT Services

Quad-C Management has acquired a majority stake in Synoptek in a recapitalization of the IT services and systems integrator. Sverica Capital Management will retain a minority position; the investment is intended to support Synoptek's organic growth and further M&A expansion. Canaccord Genuity served as financial advisor to Synoptek and Sverica.

Synova Invests Growth Capital into 3173 Limited

June 1, 2022

Financial Services

Growth investor Synova has made a growth capital investment into 3173 Limited, a Belfast-based provider of pensions administration software (Mantle), trusteeship and actuarial services. The funding will support scaling of the Mantle SaaS platform, expansion of core services into new geographies and service lines, and selective strategic acquisitions; the deal is subject to FCA approval.

Synova Makes Growth Investment in National Education Group

October 1, 2021

Education

Growth investor Synova has made a significant minority (growth-capital) investment in National Education Group (NEG), a UK-based provider of online CPD training delivered via a proprietary learning management system. The capital will support further investment in NEG’s software platform and digital content library to accelerate product development, content creation and international growth.

Synova Acquires Majority Stake in Orbis Protect from NorthEdge

June 16, 2021

Professional Services

Growth investor Synova has acquired a majority stake in Orbis Protect, a UK provider of vacant property security, with NorthEdge Fund II delivering a strong return and making a material reinvestment alongside Synova. The investment will fund Orbis' next phase of growth — including further technology investment, new products and services, M&A activity and potential European expansion.

Synova Capital Invests in Charnwood Molecular

January 1, 2020

Biotechnology

Synova Capital has completed a significant growth investment into Charnwood Molecular to support the company's next phase of expansion. The funding will be used to accelerate Charnwood’s development of higher‑value chemistry, broaden its scientific service offering, and pursue selective acquisitions to expand capabilities and address strong demand from pharma and biotech clients.